Loading…
Vericel Corporation is projected to rise to $45.83 by 2027, a +34% move from its current price of $34.27. VCEL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $33.52 | $34.29 | $35.08 | +0.06% |
| May 30 | $33.23 | $34.31 | $35.44 | +0.13% |
| May 31 | $33.01 | $34.34 | $35.72 | +0.19% |
| Jun 1 | $32.83 | $34.36 | $35.96 | +0.26% |
| Jun 2 | $32.67 | $34.38 | $36.18 | +0.32% |
| Jun 3 | $32.53 | $34.40 | $36.38 | +0.39% |
| Jun 4 | $32.41 | $34.42 | $36.56 | +0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $32.41 | $34.42 | $36.56 | +0.45% |
| Week 2 | $31.75 | $34.58 | $37.66 | +0.91% |
| Week 3 | $31.29 | $34.74 | $38.56 | +1.36% |
| Week 4 | $30.93 | $34.89 | $39.37 | +1.82% |
| Week 5 | $30.63 | $35.05 | $40.11 | +2.28% |
| Week 6 | $30.37 | $35.21 | $40.81 | +2.74% |
| Week 7 | $30.15 | $35.37 | $41.49 | +3.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vericel Corporation is a Healthcare company described as a commercial-stage biopharmaceutical business that engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. It markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc.
and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Vericel Corporation (VCEL) is in the Healthcare sector. The current price is $34.73 and the market capitalization is $1.77B, with a rank of 2088. The stock trades with notable near-term technical markers, including a 50-day simple moving average of $33.84 and a 200-day simple moving average of $35.42.
The near-term support is at $32.84 and resistance at $36.92, framing a constructive range around the current price. The 30-day price range spans from $29.68 to $40.64, and the annualized volatility is 50%. These metrics point to a stock that is balancing between support and resistance with a bullish technical backdrop according to the indicated sentiment.
A major floor 14.4% below — a decisive break under it would weaken the trend.
The nearest floor, 4.2% below — buyers have tended to step in here.
The nearest ceiling, 7.7% above — a clean break opens room to run.
A major ceiling 14.2% above — clearing it would confirm fresh momentum.
Key VCEL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VCEL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $34.90 | Sell | $34.62 | Sell |
| MA 10 | $34.29 | Sell | $34.55 | Sell |
| MA 20 | $34.56 | Sell | $34.51 | Sell |
| MA 50 | $33.92 | Buy | $34.51 | Sell |
| MA 100 | $35.14 | Sell | $34.99 | Sell |
| MA 200 | $35.41 | Sell | $36.43 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.87 | Neutral |
| Stoch RSI (14) | 50.62 | Neutral |
| CCI (20) | -18.26 | Neutral |
| Williams %R (14) | -44.14 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 2.42 | Buy |
| Bollinger %B (20,2) | 0.44 | Neutral |
| Stochastic %K (14) | 55.86 | Neutral |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | 0.22 | Buy |
| Ultimate (7,14,28) | 53.70 | Neutral |
| Momentum (10) | 1.33 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 34.97 | Sell |
| ADX (14) | 9.18 | Neutral |
| ATR (14) | 0.70 | Info |
The 30-day technical picture shows bullish sentiment overall with RSI at 50, suggesting a neutral-to-balanced momentum near the midline. The stock sits around the SMA50 of $33.84 and just under the SMA200 of $35.42, with a defined support at $32.84 and a resistance at $36.92. The 30-day range runs from $29.68 to $40.64, indicating a broad but capped move in the recent period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $29.34 | $34.27 | $46.31 | 0% | Neutral | |
| $36.93 | $45.83 | $59.88 | +34% | Bullish | |
| $38.83 | $49.27 | $66.38 | +44% | Bullish | |
| $40.32 | $52.12 | $71.94 | +52% | Bullish | |
| $42.09 | $55.31 | $77.93 | +61% | Bullish | |
| $41.31 | $55.09 | $79.04 | +61% | Bullish | |
| $46.23 | $62.51 | $91.17 | +82% | Bullish | |
| $54.83 | $75.12 | $111.19 | +119% | Bullish | |
| $58.17 | $80.68 | $121.06 | +135% | Bullish | |
| $59.46 | $83.44 | $126.81 | +143% | Bullish | |
| $84.87 | $125.57 | $201.39 | +266% | Bullish | |
| $121.68 | $196.89 | $341.81 | +475% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $29.34 | $34.27 | $40.21 | +0.00% |
| June 2026 | $30.27 | $35.42 | $42.34 | +3.36% |
| July 2026 | $30.84 | $36.34 | $43.93 | +2.60% |
| August 2026 | $30.48 | $36.12 | $44.05 | -0.61% |
| September 2026 | $30.77 | $36.62 | $44.97 | +1.38% |
| October 2026 | $31.67 | $37.85 | $46.79 | +3.38% |
| November 2026 | $31.48 | $37.76 | $46.94 | -0.25% |
| December 2026 | $30.79 | $37.06 | $46.31 | -1.86% |
Click any year to see its month-by-month VCEL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect VCEL to range from $29.34 to $46.31 through 2026. The $34.27 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The VCEL price prediction for 2027 points to an average of $45.83 (low $36.93, high $59.88) — a potential gain of +34% on today's $34.27. Momentum favours further upside here.
In 2028, VCEL is projected to trade between $38.83 and $66.38, averaging $49.27 — a potential gain of +44% from today's $34.27. That is up +8% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Vericel Corporation's 2029 outlook centres on $52.12, within a $40.32 to $71.94 range. That is up +6% on the projected 2028 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2030, VCEL could reach as high as $77.93, with a base case around $55.31 and support toward $42.09 — roughly +61% from $34.27. Buyers look set to stay in control over this stretch.
Expect VCEL to range from $41.31 to $79.04 through 2031. The $55.09 average target implies a +61% move from current prices. That is 0% versus the projected 2030 average. Momentum favours further upside here.
The VCEL price prediction for 2032 points to an average of $62.51 (low $46.23, high $91.17) — a potential gain of +82% on today's $34.27. Buyers look set to stay in control over this stretch.
In 2033, VCEL is projected to trade between $54.83 and $111.19, averaging $75.12 — a potential gain of +119% from today's $34.27. That is up +20% on the projected 2032 average. Momentum favours further upside here.
Vericel Corporation's 2034 outlook centres on $80.68, within a $58.17 to $121.06 range. That is up +7% on the projected 2033 average. That marks a +135% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, VCEL could reach as high as $126.81, with a base case around $83.44 and support toward $59.46 — roughly +143% from $34.27. Momentum favours further upside here.
Expect VCEL to range from $84.87 to $201.39 through 2040. The $125.57 average target implies a +266% move from current prices. That is up +50% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The VCEL price prediction for 2050 points to an average of $196.89 (low $121.68, high $341.81) — a potential gain of +475% on today's $34.27. Momentum favours further upside here.
Investing $1,000 in VCEL today (≈ 29.180041 VCEL) could be worth
$5,745.3
+$4,745.3 (+475%) by 2050 · US Dollar
Based on the average projected VCEL price of $196.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VCELwould be worth at today's price.
$1,000 invested in VCEL on May 27, 2025 (≈ 23.769907 VCEL) would be worth
$814.59
-$185.41 (-18.5%) today · 0.81× · US Dollar
Based on a VCEL entry price of $42.07 vs. today's $34.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $35.4 | $968.08 | -3.2% |
| 1 month ago | $36.92 | $928.22 | -7.2% |
| 3 months ago | $37.68 | $909.5 | -9.0% |
| 6 months ago | $40.25 | $851.43 | -14.9% |
| 1 year ago | $42.07 | $814.59 | -18.5% |
| All time (5.0y) ago | $56.49 | $606.66 | -39.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VCEL forecast.
Our base-case forecast reaches $69.00 around 2033.
Implied market cap at $69.00: $3.52B
The multi-year forecast highlights a rising trajectory with bullish sentiment lasting through the forecast horizon. For 2026 the average price is $34.73 with a min of $29.34 and a max of $47.48, and the ROI is 0. In 2027 the average price moves to $47.51 with a min of $38.13 and a max of $62.43, and the ROI is 36.8 with a bullish sentiment.
By 2028 the average is $50.89 (min $39.90, max $69.01) with an ROI of 46.5 and bullish sentiment, followed by 2029 at $54.03 (min $41.55, max $75.14) and ROI 55.6. The 2030 forecast shows an average of $57.77 (min $43.67, max $82.08) with ROI 66.3 and bullish sentiment, while 2031’s average is $57.17 (min $42.55, max $82.76) with ROI 64.6. The trajectory continues to 2032 with $65.98 average (min $48.39, max $97.14) and ROI 90, 2033 with $80.15 average (min $57.99, max $119.82) and ROI 130.8, 2034 with $85.02 average (min $60.72, max $128.92) and ROI 144.8, and 2035 with $88.49 average (min $62.42, max $135.95) and ROI 154.8, all with bullish sentiment.
Tap a question to reveal the answer.
2030 average price is $57.77 with a min of $43.67 and a max of $82.08; ROI is 66.3 and sentiment is BULLISH.
The forecast shows a shift to BULLISH sentiment from 2027 onward, with rising average prices: 2027 $47.51, 2028 $50.89, 2029 $54.03, 2030 $57.77, and a long-term trajectory to 2040 $134.61 and 2050 $211.96, with ROI reaching 66.3 by 2030, 287.6 by 2040, and 510.3 by 2050.
Yes. The maximum forecast for 2033 is $119.82, indicating a path that could exceed $100 in that year.
The current price is $34.73.
By 2040 the average price is $134.61 with ROI 287.6 and by 2050 the average price is $211.96 with ROI 510.3, both reflecting a bullish outlook across the long term.
Vericel Corporation Community Discussion
0Share your Vericel Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.